Association between polypharmacy and the risk of requiring long‐term care among community‐dwelling older residents: A retrospective cohort study
Open Access
- 30 June 2025
- journal article
- Published by Wiley in Journal of General and Family Medicine
- Vol. 26 (5) , 402-407
Abstract
Background: Polypharmacy has been increasing attention as it is associated with a number of health problems, especially adverse outcomes in older adults. However, there is insufficient evidence regarding the risk of polypharmacy and long‐term care.Methods: We analyzed a community‐based retrospective cohort of residents of Goto City by combining data from health checkups, prescription information, and long‐term care needs certification database. The study sample included residents aged 65–79 years in 2015 who were followed up for 4 years. The number of medications used was categorized as 0, 1–5, 6–9, and ≥10. The outcome was initiation of long‐term care. Cox regression models were used to calculate hazard ratios (HRs) with 95% confidence intervals (CIs) adjusted for potential confounders.Results: Among 1083 participants, 58 used long‐term care for 4 years. Compared with participants taking no medication, the incidence of long‐term care initiation was approximately double in those taking 1–5 medications, four times higher in people taking 6–9 medications, and 13 times higher in people taking ≥10 medications. After adjusting for potential baseline confounders, the number of medications was significantly associated with the initiation of long‐term care services (1–5 drugs: adjusted HR 2.38, 95% CI 1.06–5.34; 6–9 drugs: adjusted HR 2.97, 95% CI 1.23–7.15; and ≥10 drugs: adjusted HR 5.54, 95% CI 1.89–16.23).Conclusions: Among community‐dwelling residents aged 65–79 years, the risk of requiring long‐term care had a dose–response relationship with the number of prescribed medications.Keywords
This publication has 20 references indexed in Scilit:
- Cumulative Update of a Systematic Overview Evaluating Interventions Addressing PolypharmacyJAMA Network Open, 2024
- Association of disability level with polypharmacy and potentially inappropriate medication in community dwelling older peopleArchives of Gerontology and Geriatrics, 2022
- Social Insurance for Long-term CareJournal of Population Ageing, 2022
- Effectiveness of polypharmacy reduction policy in Japan: nationwide retrospective observational studyInternational Journal of Clinical Pharmacy, 2021
- A narrative review of evidence to guide deprescribing among older adultsJournal of General and Family Medicine, 2021
- An update on the clinical consequences of polypharmacy in older adults: a narrative reviewExpert Opinion on Drug Safety, 2018
- Association of polypharmacy and hyperpolypharmacy with frailty states: a systematic review and meta-analysisEuropean Geriatric Medicine, 2018
- Polypharmacy Is Associated With Higher Frailty Risk in Older People: An 8-Year Longitudinal Cohort StudyJournal of the American Medical Directors Association, 2017
- High-Risk Prescribing and Incidence of Frailty Among Older Community-Dwelling MenClinical Pharmacology & Therapeutics, 2012
- Emergency Hospitalizations for Adverse Drug Events in Older AmericansNew England Journal of Medicine, 2011